Bevacizumab Plus Docetaxel and Doxorubicin in Treating Patients With Previously Untreated Inflammatory or Locally Advanced Stage IIB or Stage III Breast Cancer
This study has been completed.
Study NCT00021086
Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001
Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
